California is taking decisive action to regulate private equity and hedge fund involvement in healthcare. With Gov. Newsom signing SB 351 and AB 1415, the state is codifying long-standing prohibitions on the corporate practice of medicine and dentistry while significantly expanding the Office of Health Care Affordability’s authority to review healthcare transactions – particularly those involving private equity groups, hedge funds, and management services organizations.

Join us for an in-depth discussion that breaks down:

• The key provisions of SB 351 and AB 1415, and the factors that prompted California’s legislative push.
• The immediate implications for private equity sponsors and hedge fund sponsors, and their California portfolio companies.
• The compliance challenges and structuring considerations as we approach the 2026 effective date.
• How these changes could ripple across the US and cross-border investments.

Whether you advise funds, investors, or targets with California exposure, this session will provide the practical insights and strategies needed to stay ahead of the new regulatory curve.